13F HOLDINGS REPORT
Novo Holdings A/S
Quarter ended Q3 2024 · Filed October 24, 2024 · Accession 0000950123-24-009887
Total Value
$2.01B
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 922908769 | 1,038,550 | $294.1M | 14.61% |
| 2 | TEMPUS AI INC | TEM | 4,074,419 | $230.6M | 11.45% |
| 3 | BROOKFIELD CORP | 11271J107 | 3,491,230 | $185.6M | 9.22% |
| 4 | EDGEWISE THERAPEUTICS INC | EWTX | 5,549,900 | $148.1M | 7.36% |
| 5 | CORCEPT THERAPEUTICS INC | CORT | 2,411,362 | $111.6M | 5.54% |
| 6 | ASML HOLDING N V | ASMLF | 133,336 | $111.1M | 5.52% |
| 7 | SALESFORCE INC | CRM | 368,560 | $100.9M | 5.01% |
| 8 | VAXCYTE INC | PCVX | 750,000 | $85.7M | 4.26% |
| 9 | MIRUM PHARMACEUTICALS INC | MIRM | 1,500,000 | $58.5M | 2.91% |
| 10 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,385,000 | $54.3M | 2.69% |
| 11 | ALIBABA GROUP HLDG LTD | BBAAY | 500,827 | $53.1M | 2.64% |
| 12 | INSMED INC | INSM | 724,666 | $52.9M | 2.63% |
| 13 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,000,000 | $51.1M | 2.54% |
| 14 | CABLE ONE INC | CABO | 118,403 | $41.4M | 2.06% |
| 15 | ARRIVENT BIOPHARMA INC | AVBP | 1,505,315 | $35.4M | 1.76% |
| 16 | MERUS N V | N5749R100 | 700,000 | $35.0M | 1.74% |
| 17 | BIOMARIN PHARMACEUTICAL INC | BMRN | 490,000 | $34.4M | 1.71% |
| 18 | CELLDEX THERAPEUTICS INC NEW | CLDX | 963,663 | $32.8M | 1.63% |
| 19 | ALNYLAM PHARMACEUTICALS INC | ALNY | 118,383 | $32.6M | 1.62% |
| 20 | PHARVARIS N V | PHVS | 1,725,000 | $31.9M | 1.59% |
| 21 | LANZATECH GLOBAL INC | LNZAW | 15,814,845 | $30.2M | 1.50% |
| 22 | BROOKFIELD ASSET MANAGMT LTD | 113004105 | 627,207 | $29.7M | 1.47% |
| 23 | CARGO THERAPEUTICS INC | 14179K101 | 1,544,000 | $28.5M | 1.41% |
| 24 | AMICUS THERAPEUTICS INC | FOLD | 2,500,000 | $26.7M | 1.33% |
| 25 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,100,000 | $20.3M | 1.01% |
| 26 | ZENAS BIOPHARMA INC | ZBIO | 1,150,000 | $19.5M | 0.97% |
| 27 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,500,000 | $16.2M | 0.81% |
| 28 | BLUEPRINT MEDICINES CORP | 09627Y109 | 175,000 | $16.2M | 0.80% |
| 29 | VERVE THERAPEUTICS INC | 92539P101 | 2,400,000 | $11.6M | 0.58% |
| 30 | LEXEO THERAPEUTICS INC | LXEO | 1,122,581 | $10.1M | 0.50% |
| 31 | KYVERNA THERAPEUTICS INC | KYTX | 1,850,000 | $9.0M | 0.45% |
| 32 | METAGENOMI INC | MGX | 1,800,000 | $3.9M | 0.19% |
| 33 | IO BIOTECH INC | IOBT | 3,354,449 | $3.5M | 0.17% |
| 34 | ABCELLERA BIOLOGICS INC | ABCL | 1,126,915 | $2.9M | 0.15% |
| 35 | MARQETA INC | MQ | 441,558 | $2.2M | 0.11% |
| 36 | GALECTO INC | 36322Q206 | 99,913 | $1.2M | 0.06% |
| 37 | SPERO THERAPEUTICS INC | SPRO | 468,902 | $628,329 | 0.03% |